contains one cis negative regulatory region and two heme-dependent positive regions, one of which is controlled by the transcriptional regulator CYP1 (HAP1) which is involved in the modulation of the expression of several oxygen-regulated genes. The CYP1 (HAPl)-binding sequence was located by gel retardation and DNase I footprinting experiments and compared with the binding sequences previously characterized in detail (UASlcyc,1 UAS'c,p3 (cyc7') and UASc7iT).
Studies on the regulation of nuclear genes encoding mitochondrial proteins should provide a major contribution to our understanding of mitochondrial biogenesis in Saccharomyces cerevisiae. Several variables, including glucose fermentation, oxygen tension in the growth medium, and the availability of heme, are of particular interest because they all elicit significant changes in the levels of mitochondrial proteins of nuclear origin needed for the maintenance of a respiratory functional organelle. In this respect, the regulation of the expression of the respiratory components iso-icytochrome c (CYCI) and iso-2-cytochrome c (CYP3 or CYC7) has been investigated (26, (32) (33) (34) 45) . Detailed in vivo and in vitro studies of the upstream regions of both genes have demonstrated that their regulation is effected by positive elements which are known as upstream activation sites (UASs) (10, 21, 46) . Within these elements, sequences have been identified which are the specific binding sites for characterized transcriptional activators (30) . The transcriptional activator CYP1 (HAP1) (40) was shown to modulate the expression of CYCI and CYP3 (CYC7) through an interaction with specific sequences: UAS1 for CYCI and UAS' for CYP3 (CYC7) (30) . The CYPI (HAPI) gene product could have a more general function as a coordinator of the activity of genes encoding proteins involved in various aspects of oxygen metabolism. Recently it has been shown that the expression of CTTJ (encoding catalase T) and HMGI (encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase) is also mediated by the CYP1 (HAP1) transcriptional regulator (39, 44) . In vivo CYPI-dependent UASs activity was found to be induced by heme (9) . By using extracts, CYP1 (HAP1) binding to specific target sequences has been shown to be induced by hemin in vitro (12, 20, 30) , suggesting that heme could serve directly as a ligand as steroids do for some hormone receptors in mammals (la) .
The CYPI (HAPJ) gene has been cloned, and its sequence * Corresponding author.
has been determined (7, 29, 41) . It encodes a protein of 1,483 amino acid residues which can be divided into three functional domains (7, 17, 18, 29, 42) . At the N terminus there is a zinc finger domain which is involved in binding to specific DNA sequences (UASs). At the carboxyl end there is an acidic region necessary for transcriptional activation. Finally, in the middle of the protein, a distinct region which mediates heme induction has been characterized.
Yeast L-(+)-lactate cytochrome c oxidoreductase, or cytochrome b2, is a soluble protein from the intermembrane space of mitochondria (13) . It catalyzes the transfer of electrons from L-(+)-lactate to cytochrome c, which involves the formation of a specific complex between the two molecules (2, 19) . At present, it is not clear whether cytochrome b2 interacts preferentially with iso-i-or iso-2-cytochrome c during the electron transfer process. The level of cytochrome b2 activity measured in crude extracts has been shown to be subject to respiratory adaptation (23, 34) , and it was observed by Clavilier et al. (5) that the presence of the mutation CYPI-18 considerably diminished cytochrome b2 activity in the cell. Recently, the C YB2 gene has been isolated and sequenced (12) .
In this work we investigate the regulation of CYB2 expression by direct analysis of mRNA transcripts and by the measurement of the expression of lacZ fused to the CYB2 control regions. We have also analyzed how the CYPI (HAP1) product, identified as a positive transactive factor (8, 39, 41, 43, 44) , exerted its control on the expression of the CYB2 gene. In particular, we have identified the region upstream of the CYB2 transcriptional start site that mediates CYPI (HAP]) activity. The implications of these findings for preferential transcriptional coordination between CYB2 and CYCI are discussed. Labbe (Paris), and VP209-7B ACYP1 (MATa ura3 cycl-l cypl::LEU2), VP209-7B AHEM1 (MATTa ura3 cycl-J heml ::LEU2), and DBY-U4 (MATa Ahis3 leu2 3-112 trpl-25 cyb2:: URA3) which were constructed in this laboratory.
Growth conditions. Yeast cells were grown on complete medium consisting of 2% yeast extract, 1% Bacto-Peptone (Difco Laboratories), and a carbon source: 10% glucose (repressed conditions or 2% galactose, 2% raffinose, 2% ethanol, or 2% lactate (unrepressed conditions). Minimal medium (0.67% yeast nitrogen base without amino acids), contained carbon sources as indicated above, the required amino acids at 40 ,ug/ml, and adenine or uracil at 20 ,ug/ml.
Transformation. E. coli was transformed by the method of Mandel and Higa (24) . Yeast transformation was carried out by the LiCl procedure of Ito et al. (16) .
DNA manipulation. Restriction endonucleases, T4 DNA ligase, alkaline phosphatase from calf intestine, DNA polymerase I, the large fragment from E. coli, DNase I, and T4 polynucleotide kinase were obtained from Biolabs and Boehringer and used in accordance with the supplier's recommendations. DNA sequencing was performed by the method described by Maxam and Gilbert (27) . Restriction fragments were 5' end labelled with T4 polynucleotide kinase (25) .
Oligonucleotide synthesis. Oligonucleotides were synthesized with a model 7500 DNA synthesizer (Milligen) and purified by gel electrophoresis. The sequences of synthetic DNA fragments used as competitors in protein-DNA binding assays are shown in Fig. 8 .
DNA preparation. Bacterial plasmids were prepared by an alkaline lysis protocol (25) .
Electrophoresis of RNA, transfer to nitrocellulose sheets, and hybridization. Total RNA prepared by the method described by Maccechini et al. (23) was subjected to agarose gel electrophoresis in 50 mM boric acid-S mM borate-10 mM sodium sulfate-S mM methyl-mercuric hydroxide. After transfer to nitrocellulose filters, the RNA was hybridized with nick-translated DNA probes (38) . In order to normalize for the amounts of mRNA, the same blots were rehybridized with an actin (ACTI) probe, which provides a reliable standard.
Deletion experiments in the 5'-flanking region of CYB2. The 5-kb HindIII fragment from the recombinant plasmid pGB5C2R5 (12) , which contains the entire CYB2 gene plus 2 kb of its 5'-flanking region, was subcloned into the shuttle vector YEp351 (14) and pUC19 (47) to give the recombinant plasmids YEp2000 and pGB2000, respectively. Deletions in the 5'-flanking region of the CYB2 gene were obtained by digestion of plasmid pGB2000 with HindIII and partial digestion with BglII, NheI, EcoRV, or Sall. The obtained fragments (-446 to +2500, -250 to +2500, -230 to +2500, -137 to +2500, and -91 to +2500) were subcloned into restriction sites of the multiple cloning region of the shuttle vector YEp351 to give the recombinant plasmids YEp446, YEp250, YEp230, YEp137, and YEp91, respectively.
Western immunoblot analysis. Western blots were carried out as described by Guiard (12) . Proteins were separated electrophoretically on 9% sodium dodecyl sulfate-polyacrylamide gels, electrophoretically transferred to nitrocellulose, and then analyzed by immunoblotting with polyclonal antibodies against the cytochrome b2 protein.
Identification of cis-acting regulatory elements involved in the transcriptional control of CYB2. DNA subfragments of different lengths from the region -446 to -91 were obtained by using the restriction sites present (BglII, NheI, EcoRV and SaiI) and cloned into the multiple cloning site polylinker of the plasmid pUC19. They were recovered by cutting with SmaI and Sall enzymes and were then ligated into the SmaI and XhoI sites of the CYCI-lacZ fusion vector pLG669Z (9) in place of the CYCI upstream activating sequences, as shown in Fig. 4 . The DNA fragment which covers positions -250 to -200 of the CYB2 promoter and which is flanked by SmaI and SalI restriction sites was synthesized.
Enzyme assays. ,-Galactosidase activity was assayed in yeast cells permeabilized with chloroform and sodium dodecyl sulfate as previously described by Guarente et al. (11) . For each plasmid, a minimum of two transformants was assayed in triplicate, and values representing an average of three experiments (performed on separate days) were reported and expressed in Miller units (11) .
Probes for electrophoresis DNA binding assays and footprinting. CYB2 promoter fragments were derived from the plasmid pGB300, which contains the 309-bp BglII (-446 (23), and hybridization was carried out using the nick-translated 1.2-kb BamHI-BglII fragment from plasmid pGB5C2H2 as a probe (12) . Each lane contained EDTA, 100 mM NaCI) with 0.5 pug of sonicated salmon sperm DNA per ml. Extracted DNA was purified by absorption to Elutip-d columns (Schleicher and Schuell), eluted with 0.4 ml of buffer A containing 1 M NaCl, and ethanol precipitated. The DNA was then heated at 90°C for 5 min in denaturing buffer, chilled in ice, and loaded onto a 6% polyacrylamide denaturing gel (urea 6 M, TBE). DNA sequencing was performed by the method of Maxam and Gilbert (27) .
Nucleotide sequence accession number. The nucleotide sequence data reported in this paper have been submitted to EMBL and GenBank and assigned accession number X03215.
RESULTS
Effect of carbon sources on CYB2 mRNA synthesis. The level of cytochrome b2 activity in S. cerevisiae is mainly related to growth conditions and to the effects of different carbon sources (35) . To determine whether this regulation affects the CYB2 mRNA level, we performed Northern (RNA) blot experiments with mRNA extracted from cells grown under different conditions. The wild-type strain D261 (CYPI+) was used, and the CYB2 mRNA was identified by using the nick-translated BamHI-BglII (+490 to + 1668) fragment containing a large internal CYB2 coding sequence (12) . The results presented in Fig. 1 show that the CYB2 mRNA level is too low to be detectable when glucose is used as carbon source. CYB2 mRNA synthesis is derepressed in aerobic cells grown on ethanol or lactate. amount of CYB2 transcript was also investigated with respect to anaerobiosis and aerobiosis with cells grown on galactose. The results are illustrated in Fig. 2A and show that CYB2 transcripts from the wild-type strain D261 cannot be detected under anaerobic conditions, whereas they accumulate in aerobic conditions. It has also been observed that heme exerts a positive control over the synthesis of many heme-containing proteins (15) . To examine the effect of heme on expression of the CYB2 gene we used the strain Ole3-2b that carries a mutation in HEM], the structural gene for 8-aminolevulinic acid synthetase (the first enzyme in the heme biosynthesis pathway), and is consequently deficient in heme biosynthesis and respiration. Our analysis was done with cells grown on raffinose. Under these conditions (Fig.  2B) (HAPI) locus (43) was used, and the level of CYB2 transcripts has been investigated by Northern blotting. The results of these experiments are presented in Fig. 1 and show that the level of CYB2 mRNA in this genetic context and especially under ethanol growth conditions is significantly reduced. Nevertheless, with the cypl-23 mutant, the transcriptional induction by lactate is conserved but the wildtype level of mRNA is not attained.
Deletion analysis of the upstream region of the CYB2 gene. The deletions in the upstream region of CYB2 are illustrated in Fig. 3 Table 2 , were grown in minimum media supplemented with 2% galactose or with 2% galactose plus 30 pLg of ergosterol per ml and 0.2% Tween 80, respectively. P-Galactosidase activity was assayed as described in Materials and Methods.
moter. Important sequences for the control of gene expression are often dispersed in the region upstream from the transcription initiation site. The transcriptional start site for the CYB2 gene has been located between positions -34 and -44 upstream of the ATG site (12) . On the basis of the experiment described above (Fig. 3) , we constructed a set of plasmids containing DNA subfragments of different lengths from the region -446 to -90 which had been cloned into a CYCI-lacZ fusion vector in place of the CYCI upstream activating sequences (UASs) in order to define regions upstream of CYB2 required for its expression (Fig. 4) . The resulting plasmids were transformed into the wild-type strain VP209-7B (CYPI+), and transformants were assayed for 3-galactosidase activity under different metabolic conditions (Table 1) . Mutant strains were constructed in which the Table 2 and 3, respectively. Data obtained from these experiments demonstrate that the fragment -446 to -137 inserted into the pLGB1 construction permits all the regulatory effects already revealed by the mRNA analysis. This hybrid promoter presents high sensitivity to the growth conditions and is strongly affected by the cypl and the hem] mutations. In unrepressed galactose conditions the effect of the hemi mutation is stronger than that of the cypl mutation. In addition, this sequence can be inverted without an impairment of its activity (pLGB1 and pLGB2 constructions). The removal of the region -200 to -137 (pLGB3 construction) decreases only the glucose repression effect in the wild-type strain, compared with the pLGB1 or pLGB2 construction.
The same experiments performed with the constructions pLGB9 and pLGB4 allow the characterization of two cisacting positive regulatory elements. The first is in a DNA fragment of 50 bp from the pLGB9 construction; it requires heme biosynthesis to maintain its activating property (Table   3) , and disruption of the CYPI (HAPJ) gene exerts a major Fig. 4 . b Plasmids were transformed into strain VP209-7B ACYP1 (cypl HEMI). effect on expression mediated by this UAS ( Table 2 ). This region has been named UAS1-B2. An interesting observation was made with the pLGB7 construction, which contains the fragment -250 to -137 and which shows a low level of activity compared with that of the pLGB9 construction, which contains the fragment -250 to -200 (Table 1) . From the comparison of the pLGB7 and pLGB9 constructions we can deduce that the region -200 to -137 contains an element which is able to exert a negative effect on UAS1-B2 activity and which is neutralized by the presence of the 5' region -446 to -250. The second cis-acting positive regulatory element, UAS2-B2, is located in a wide region between -230 and -446 (pLGB4 construction). Its activating properties are related to the growth conditions (repression with glucose utilization, derepression with ethanol, and induction with lactate compared with ethanol) and are affected by the absence of heme biosynthesis but are independent of the product of CYPI (HAP1) gene (Tables 1, 2 , and 3). Localization of the binding site of the CYPI (HAPI)-dependent complex. The binding of proteins to the labelled 323-bp BglII fragment of the CYB2 promoter was analyzed in a CYP1+ and cypl mutant context by using a DNA gel retardation assay. When a crude cell extract of the wild-type strain (grown on 2% galactose) was tested, several complexes were observed ( Fig. SA and B) . We attribute the retardation band with the higher molecular weight to a specific CYPJ (HAPJ)-dependent complex by virtue of the following arguments.
(i) This retardation band is absent when a cypl-negative cell extract is tested (Fig. 5) .
(ii) Specific competition is observed when an unlabelled DNA fragment containing the UAS1 region of CYC1 (Fig. 5) [whose sequence has been identified by Pfeifer et al. (30) as a target of the CYPJ (HAP)) product] is added.
(iii) The binding is strongly increased when heme is added to the incubation mixture. This stimulation by heme in vitro is a property of the formation of CYPJ (HAPJ)-dependent complexes and has been demonstrated for the interactions of CYPJ (HAP)) with the UAS1 of CYCI (20) , with the UAS' of CYP3 (CYC7) (30) , and with the UASCTTI of CTTI (44) .
The amount of CYP) (HAP])-dependent complex is increased by the addition of MgCl2 and heme to the incubation mixture; however, MgCl2 alone appears to have no effect.
The Mg2+ ions could contribute to the interaction or could stabilize the complex in the presence of heme by an independent or synergistic effect. In subsequent experiments, the incubation mixture always contained MgCl2 (5 Fig. 8 .
To localize the CYPI (HAPJ)-dependent protein-binding site, crude extracts of strain VP209-7B (CYPI +) were prepared and tested for their ability to form complexes with the labelled CYB2 promoter fragments. As shown in Fig. 6 The protected DNA region in the CYPI (HAPJ)-dependent complex was determined by DNase I footprinting experiments. As shown in Fig. 7 , a 22-bp protected region (-239 to -218) is observed. This sequence covers the EcoRV site, as was predicted by DNA retardation experiments. To corroborate this result, oligonucleotides which contained strictly the CYPJ (HAPJ)-binding site from the CYCI, CYP3 (CYC7), and CYB2 promoters were synthesized and used as specific competitors in the interaction between the CYPI product and the labelled DNA fragment (40 ,uM) and MgCl2 (5 mM) and treated with DNase I. Free (F) and bound (B) DNA were separated on a 5% polyacrylamide gel, eluted, and then analyzed on a standard 6% sequencing gel by the method of Maxam and Gilbert (27) . The protected sequence (-239 to -218) is bracketed.
NheI-Bgil (-250 to -137). These three oligonucleotides are effective competitors of UAS1-B2 (Fig. 8, lines 2, 3, and 4) . In this experiment, an oligonucleotide with a sequence unrelated to that of the CYP1 (HAPl)-binding site (Fig. 8,  line 5 ) was used as a negative control and shows that the competition observed with the three binding sites is specific.
DISCUSSION
In this paper we have shown that the carbon and oxygen sources are the major regulatory factors which determine the steady-state level of CYB2 mRNA. Growth of cells in high concentrations of glucose or in the absence of oxygen, deficiency in heme biosynthesis, and mutations affecting the CYPI (HAP)) locus have similar effects on the synthesis of cytochrome b2: the steady-state level of its mRNA is strongly reduced. What is the precise relationship between these factors? The mechanism(s) by which growth on glucose causes repression of many genes is unknown, but genetic analyses of glucose repression done in recent years have identified several genes involved in this general regulatory system which affect a large number of genes besides those encoding apoheme proteins (3) . Mutations in these genes should be tested for their effect on CYB2 regulation. Anaerobic regulation could be reduced to the single parameter of intracellular heme concentration, as has been proposed by Guarente et al. (9) . In that case the heme concen- (40 ,uM) and MgCl2 (5 mM). Lane (HAPI) gene plays an interesting role in the regulation of CYB2. Analysis of CYB2 mRNA from a cypl mutant demonstrates that the CYPI (HAPJ) gene product also exerts a positive control on the expression of CYB2, as it does for CYCI, CYP3 (CYC7), CTTJ, and HMGJ expression (8, 39, 40, 44) . In this genetic context the induction by lactate remains possible, even if the mRNA level of CYB2 does not reach the level of the wild-type strain. From these results we can propose that a specific induction of CYB2 transcription by lactate exists and can act either independently of the CYPI (HAPI) locus or in a synergistic manner.
A detailed study of the 5'-flanking sequence of the CYB2 gene (Fig. 9 ) reveals that most of the cis regulatory sites are located between nucleotides -446 and -90. A dissection of this region gives rise to a working model and a possible explanation of how transcription of the CYB2 gene is regulated (Fig. 10) . According to our results, CYB2 is mainly regulated via three functionally distinct cis-acting elements (two positive and one negative) present in the DNA fragment spanning nucleotides -446 to -137. The two positive regions have the general characteristics of the upstream activation sequences described above in the transcriptional control of a large number of genes in S. cerevisiae. The activity of the first one (from -250 to -200), UAS1-B2, is abolished in the heme-depleted hemi mutant and in a strain carrying a cypl::LEU2 disruption. These data demonstrate that heme-stimulated UAS1-B2 activity is mediated by the action of the CYP1 (HAP1) transcriptional activator, as has been shown by Guarente et al. (8) and Pfeifer et al. (29) for UAS1 of the CYCl gene. The second upstream activation site, UAS2-B2, is contained in a large fragment of DNA (-446 to -250) and has not been precisely localized. Its activity is repressed by glucose, derepressed in response to the shift to nonfermentable carbon sources such ethanol, and induced by lactate, compared with ethanol. It is not under the control of CYPI (HAPJ) gene, but it is affected by the absence of heme biosynthesis. This activation region presents some close similarities with UAS2 of CYCI, whose activity is controlled by the HAP2, HAP3, and HAP4 products (8) . These two CYB2 UASs elements show strong synergistic effects in their activity, as has been demonstrated between UAS1 and UAS2 of CYCI. Preliminary results show that CYB2 transcription is affected in the hap2-1 mutant strain from the Guarente laboratory (1). Identification of the cis-acting region involved in this process is in progress. The third region, between -200 and -140 and downstream from UAS1-B2, can directly or indirectly repress the activation effect of the CYPI (HAPJ) gene and could be the target site for a negatively acting factor. This effect is suppressed when the region -446 to -250 is present. At present we cannot decide whether this last effect is due to UAS2-B2 itself or to another cis-acting element present in the fragment -446 to -250. In addition, the presence of this third region increases the glucose repression 10-fold and could be involved in the catabolic repression process. In a significant number of cases, a DNA region associated with the negative control of yeast gene regulation has been described (36, 46) . In the regulation of CAR] transcription, a 9-bp palindromic sequence, AGCCGCCGA, which possesses characteristics of a repressor-binding site has been shown by Sumrada and Cooper to play a central role in the induction process (37) . The DNA fragment containing this upstream repression sequence has been called URS and can be specifically neutralized by a cisacting element, the upstream induction sequence, associated with CAR] induction (37) . Its insertion 3' to the CYCI UAS1 inhibits the transcriptional activity of this UAS. Related (30, 44) . In Fig. 11 (17, 29) . The fact that UAS' of CYP3 (CYC7) also competes for binding to CYP1 (HAP1) with UAS1-B2 of CYB2 and UAS1 of CYCJ suggests, as has been proposed by Pfeifer et al. (29) , that the DNA-binding domain of CYP1 (HAP1) could contain several overlapping DNArecognition sites. In addition, another example has been reported in the case of a liver DNA-binding protein (6) . This molecule is able to specifically recognize multiple nucleotide sites in regulatory regions of transthyretin, a1-antitrypsin, albumin, and simian virus 40 genes, which contain only minimal sequence similarities. With this study of CYB2 transcription, we have added a new example to the growing list of genes whose expression is regulated by oxygen tension in the growth medium and by the intracellular heme level and which are activated by CYPI. Our investigation provides new data which allow a better understanding of the coregulation of the genes encoding proteins involved in various aspects of oxidative metabolism in different subcellular compartments and which also emphasize the role of the CYPI gene product as a regulator in this process. With the involvement of the HAP2 gene in the regulation of CYB2 (1) and CYCI, we indicate a particular and subtle coregulation mechanism of both genes.
Finally, we have shown that the transcriptional machinery which controls CYB2 expression involves complex molecular interactions; experiments aimed at a more detailed characterization of the CYB2 cis-acting regions and the identification of new trans-acting factors are in progress.
